” FSD Pharma would have three point nine million square feet of facility to produce 400 thousand kg of cannabis year over year. This year we will seek a listing on a major U.S. exchange and we also have an interest to acquire a synthetic cannabinoid company that is advancing research and development of FDA approved application at FSD Pharma. We are all inspired by science and driven by a scientific innovation.” -Co-Chairman & CEO Raza Bokhari.
Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.
For more information on FSD Pharma (HUGE:CSE) please fill out the form below.